MSF Field Research

[Snowy Owl]

MSF Field Research

http://fieldresearch.msf.org/msf/

MSF is well known for its humanitarian medical work, but it has also produced important research based on its field experience with vulnerable populations. Its studies have been published in over 90 peer-reviewed journals and have often changed clinical practice and been used for humanitarian advocacy. This website archives MSF's scientific articles and makes them available free, with full text, and in an easily searchable format. No login required. We thank the many publishers who gave us permission to archive on this site. MSF authors, please notify me through Feedback if your articles are missing.

• Published Research and Commentaryfor PubMed articles
• We also include Conference Abstracts,
• MSF's Ethics Review Board,
• Programme Descriptions that give lessons learned from the field
• and our Collaborating Partners.

Finally, we invite you to send us comments about the website, published articles or other subjects via Feedback. All suitable comments will be posted here.



Latest submissions
<table cellpadding="2" cellspacing="5"><tbody><tr valign="middle"> <td class="greycell">

</td> <td> Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
Cox, Helen, Kebede, Yared, Allamuratova, Sholpan, Ismailov, Gabit, Davletmuratova, Zamira, Byrnes, Graham, Stone, Christine, Niemann, Stefan, R?sch-Gerdes, Sabine, Blok, Lucie, Doshetov, Daribay

</td></tr><tr valign="middle"> <td class="greycell">

</td> <td> Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures.
Cox, Helen S, Kalon, Stobdan, Allamuratova, Sholpan, Sizaire, Vinciane, Tigay, Zinaida N, R?sch-Gerdes, Sabine, Karimovich, Hamraev A, Kebede, Yared, Mills, Clair

</td></tr><tr valign="middle"> <td class="greycell">

</td> <td> Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
Cox, Helen S, Niemann, Stefan, Ismailov, Gabit, Doshetov, Daribay, Orozco, Juan Daniel, Blok, Lucie, R?sch-Gerdes, Sabine, Kebede, Yared

</td></tr><tr valign="middle"> <td class="greycell">

</td> <td> Effect of multidrug resistance on global tuberculosis control.
Cox, Helen, Hargreaves, Sally, Ismailov, Gabit

</td></tr><tr valign="middle"> <td class="greycell">

</td> <td> The 'diagonal' approach to Global Fund financing: a cure for the broader malaise of health systems?
Ooms, Gorik, Van Damme, Wim, Baker, Brook K, Zeitz, Paul, Schrecker, Ted
</td></tr></tbody></table>

​